Analysis shows Vg9Vd2 T cells exhibit altered differentiation profiles in TNBC, suggesting implications for anti-PD-1 treatments.
Vg9Vd2 T cells display skewed differentiation profiles towards an early effector memory phenotype in untreated and PD–1 blockade–treated TNBC (scRNA–seq, related to Figure 3).
No takes yet. Share an insight, caveat, or question.
Fattori et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: